PMID- 33987370 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220423 IS - 2305-5839 (Print) IS - 2305-5847 (Electronic) IS - 2305-5839 (Linking) VI - 9 IP - 8 DP - 2021 Apr TI - Large HDL(2) combined with inflammatory factors as superior predictors for coronary artery disease than small HDL(3). PG - 672 LID - 10.21037/atm-21-948 [doi] LID - 672 AB - BACKGROUND: This study investigated whether combinations of high-density lipoprotein (HDL) subfractions and inflammatory markers would add value to coronary artery disease (CAD) prediction. METHODS: Non-CAD subjects (n=245) were stratified into low/moderate/high-Framingham risk (L/M/H-FR) groups and 180 CAD patients were enrolled. Levels of HDL-C, HDL(2), HDL(3), monocyte chemoattractant protein-1 (MCP-1), and high-sensitivity C-reactive protein (hsCRP) were measured. Multivariable logistic models for CAD were estimated with a single parameter or all parameters together after adjustment for conventional risk factors (CRFs), and Z statistics, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to compare discrimination among different models. RESULTS: The results show that HDL-C, HDL(2,) and HDL(3) gradually decreased, while MCP-1 and hsCRP gradually increased from L/M/H-FR to the CAD group. When applying a single factor in the CRFs-adjusted models, HDL-C (OR 0.011, 95% CI, 0.002-0.071, P<0.05) and HDL(2) (OR 0.000072, 95% CI, 0.000001-0.004, P<0.05), but not HDL(3), were significantly related to CAD risk. Only HDL(2) (OR 0.000072, 95% CI, 0.000001-0.004, P<0.001) remained significant when applying all HDL parameters. In the model including all HDL and inflammatory parameters, HDL(2) (OR 0.001, 95% CI, 0.000027-0.051), MCP-1 (OR 1.066, 95% CI, 1.039-1.094), and hsCRP (OR 1.130, 95% CI, 1.041-1.227) showed significant differences (all P<0.05). This combined model showed improved discrimination over the models with a single factor (P<0.05) or all HDL parameters (Z=3.299, NRI =0.179, IDI =0.081, P<0.001). CONCLUSIONS: Large HDL(2) is superior to small HDL(3) in the inverse association with CAD. The combination of HDL(2), MCP-1, and hsCRP with CRFs provides an optimal prediction for CAD. CI - 2021 Annals of Translational Medicine. All rights reserved. FAU - Wu, Xiaoying AU - Wu X AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - He, Zhijian AU - He Z AD - Cardiovascular Medicine Department, The First Affiliated Hospital/School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, China. FAU - Sun, Runlu AU - Sun R AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Xie, Xiangkun AU - Xie X AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Chen, Qingqun AU - Chen Q AD - Cardiovascular Medicine Department, Qingyuan People's Hospital, Qingyuan, China. FAU - Wang, Junjie AU - Wang J AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Bao, Jinlan AU - Bao J AD - Comprehensive Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Huang, Jingjing AU - Huang J AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Jiang, Yuan AU - Jiang Y AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Zhang, Yuling AU - Zhang Y AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. FAU - Wang, Jingfeng AU - Wang J AD - Cardiovascular Medicine Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. LA - eng PT - Journal Article PL - China TA - Ann Transl Med JT - Annals of translational medicine JID - 101617978 PMC - PMC8106016 OTO - NOTNLM OT - Coronary artery disease (CAD) OT - combined prediction OT - high-density lipoprotein subfractions (HDL subfractions) OT - high-sensitivity C-reactive protein (hsCRP) OT - monocyte chemoattractant factor-1 COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-21-948). The authors have no conflicts of interest to declare. EDAT- 2021/05/15 06:00 MHDA- 2021/05/15 06:01 PMCR- 2021/04/01 CRDT- 2021/05/14 07:03 PHST- 2021/05/14 07:03 [entrez] PHST- 2021/05/15 06:00 [pubmed] PHST- 2021/05/15 06:01 [medline] PHST- 2021/04/01 00:00 [pmc-release] AID - atm-09-08-672 [pii] AID - 10.21037/atm-21-948 [doi] PST - ppublish SO - Ann Transl Med. 2021 Apr;9(8):672. doi: 10.21037/atm-21-948.